...
首页> 外文期刊>The Journal of Urology >Re: Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer
【24h】

Re: Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer

机译:回复:雄激素受体的过表达增强了前列腺癌中该受体与染色质的结合

获取原文
获取原文并翻译 | 示例
           

摘要

Androgen receptor (AR) is overexpressed in the majority of castration-resistant prostate cancers (CRPCs). Our goal was to study the effect of AR overexpression on the chromatin binding of the receptor and to identify AR target genes that may be important in the emergence of CRPC. We have established two sublines of LNCaP prostate cancer (PC) cell line, one overexpressing AR 2-3-fold and the other 4-5-fold compared with the control cells. We used chromatin immunoprecipitation (ChIP) and deep-sequencing (seq) to identify AR-binding sites (ARBSs). We found that the number of ARBSs and the AR-binding strength were positively associated with the level of AR when cells were stimulated with low concentrations of androgens. In cells overexpressing AR, the chromatin binding of the receptor took place in 100-fold lower concentration of the ligand than in control cells. We confirmed the association of AR level and chromatin binding in two PC xenografts, one containing AR gene amplification with high AR expression, and the other with low expression. By combining the ChIP-seq and expression profiling, we identified AR target genes that are upregulated in PC. Of them, the expression of ZWINT, SKP2 (S-phase kinase-associated protein 2 (p45)) and FEN1 (flap structure-specific endonuclease 1) was demonstrated to be increased in CRPC, while the expression of SNAI2 was decreased in both PC and CRPC. FEN1 protein expression was also associated with poor prognosis in prostatectomy-treated patients. Finally, the knock-down of FEN1 with small interfering RNA inhibited the growth of LNCaP cells. Our data demonstrate that the overexpression of AR sensitizes the receptor binding to chromatin, thus, explaining how AR signaling pathway is reactivated in CRPC cells.
机译:在大多数去势抵抗性前列腺癌(CRPC)中,雄激素受体(AR)过表达。我们的目标是研究AR过度表达对受体的染色质结合的影响,并确定可能对CRPC产生重要的AR目标基因。我们已经建立了LNCaP前列腺癌(PC)细胞系的两个亚系,一个与对照细胞相比过表达AR 2-3倍,而另一个4-5倍。我们使用染色质免疫沉淀(ChIP)和深度测序(seq)来识别AR结合位点(ARBS)。我们发现,当低浓度的雄激素刺激细胞时,ARBS的数量和AR结合强度与AR水平呈正相关。在过表达AR的细胞中,受体的染色质结合发生在配体浓度比对照细胞低100倍的情况下。我们证实了两种PC异种移植中AR水平与染色质结合的关联,其中一种包含AR基因扩增,AR表达高,而另一种表达低。通过结合ChIP-seq和表达谱,我们鉴定了PC中上调的AR目标基因。其中,CRPC中ZWINT,SKP2(S期激酶相关蛋白2(p45))和FEN1(瓣结构特异性核酸内切酶1)的表达增加,而SNAI2的表达均在CRPC中降低和CRPC。在前列腺切除术治疗的患者中,FEN1蛋白表达还与不良预后相关。最后,用小干扰RNA敲低FEN1抑制了LNCaP细胞的生长。我们的数据表明,AR的过表达使受体与染色质结合敏感,从而解释了AR信号通路如何在CRPC细胞中重新激活。

著录项

  • 来源
    《The Journal of Urology》 |2013年第2期|共2页
  • 作者

    AtalaA.;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号